These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25124080)

  • 1. Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro.
    Gannon NP; Vaughan RA; Garcia-Smith R; Bisoffi M; Trujillo KA
    Int J Cancer; 2015 Feb; 136(4):E197-202. PubMed ID: 25124080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism.
    Vaughan RA; Gannon NP; Mermier CM; Conn CA
    J Physiol Biochem; 2015 Dec; 71(4):679-89. PubMed ID: 26399516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes.
    Kurdiova T; Balaz M; Mayer A; Maderova D; Belan V; Wolfrum C; Ukropec J; Ukropcova B
    Peptides; 2014 Jun; 56():1-7. PubMed ID: 24642356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway.
    Mohapatra P; Satapathy SR; Das D; Siddharth S; Choudhuri T; Kundu CN
    Toxicol Appl Pharmacol; 2014 Mar; 275(3):221-31. PubMed ID: 24467951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines.
    Moon HS; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):188-93. PubMed ID: 24268368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Browning of white fat: does irisin play a role in humans?
    Elsen M; Raschke S; Eckel J
    J Endocrinol; 2014 Jul; 222(1):R25-38. PubMed ID: 24781257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of oracin on reduction and toxicity of doxorubicin in hepatocytes and mammary epithelial cells MCF-10A.
    Hanušová V; Boušová I; Pakostová A; Skálová L
    Xenobiotica; 2012 Jun; 42(6):571-9. PubMed ID: 22217270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the exercise-inducible myokine irisin on proliferation and malignant properties of ovarian cancer cells through the HIF-1 α signaling pathway.
    Alizadeh Zarei M; Seyed Hosseini E; Haddad Kashani H; Ahmad E; Nikzad H
    Sci Rep; 2023 Jan; 13(1):170. PubMed ID: 36599894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicin.
    Scherbakov AM; Lobanova YS; Andreeva OE; Shatskaya VA; Krasil'nikov MA
    Biosci Rep; 2011 Apr; 31(2):137-43. PubMed ID: 20662767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
    Ramachandran C; Rodriguez S; Ramachandran R; Raveendran Nair PK; Fonseca H; Khatib Z; Escalon E; Melnick SJ
    Anticancer Res; 2005; 25(5):3293-302. PubMed ID: 16101141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
    Park SJ; Wu CH; Safa AR
    Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
    Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
    Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
    Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
    Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
    Chovolou Y; Wätjen W; Kampkötter A; Kahl R
    Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
    Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
    Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.